ClinicalTrials.govpublic full text
Immune Modulation Study in Patients With Metastatic Melanoma Treated With Anti-PD1 Monoclonal Antibodies
metastatic melanoma, melanoma, anti-pd1 monoclonal antibodies, immune modulation, braf, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 851367
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.